EX-99.1 3 a03-4458_2ex99d1.htm EX-99.1

Exhibit 99.1

 

 

Contact:

 

Sharps Compliance Corp.
www.sharpsinc.com
(713) 432-0300

David P. Tusa

Senior Vice President &

Chief Financial Officer

dtusa@sharpsinc.com

 

SHARPS COMPLIANCE CORP. ANNOUNCES FIRST QUARTER OF
FISCAL YEAR 2004 RESULTS

 

HOUSTON, Texas, (November 3, 2003) — Sharps Compliance Corp. and subsidiaries (OTC BB: SCOM) (“Sharps” or the “Company”), leading providers of cost-effective medical waste disposal solutions for industry and consumers, announced its operating results for the quarter ended September 30, 2003.

 

For the three months ended September 30, 2003, the Company generated revenues of $2.0 million which was virtually flat when compared to the prior year first quarter revenue.

 

The Company realized an improved gross margin of 39% for the quarter ended September 30, 2003 versus a gross margin of 33% for the corresponding quarter of the prior year.

 

The Company reported an operating loss of $0.1 million for the quarter ended September 30, 2003, an improvement over the operating loss for the quarter ended September 30, 2002 of $0.2 million.

 

Regarding the results, Dr. Burt Kunik, Chairman, Chief Executive Officer and President of Sharps Compliance Corp. stated, “Although, the revenues for the quarter were slightly below our expectations, we are very pleased with the significant improvement in our gross margins to the near 40% level as well as the narrowing of our quarterly operating loss. This improved performance is a direct result of our refocus on pricing, operational efficiencies and an aggressive cost reduction program.”

 

Kunik added, “We are extremely focused on closing a number of sales opportunities in the industrial, commercial and other markets during the fiscal year 2004. Revenue from these opportunities is a critical component to our fiscal year 2004 Plan expectations. Additionally, our Plan reflects the continuing improvement in our gross margins as well as stability in our quarterly overhead. Achievement of the above should result not only in revenue growth but also significantly improved bottom-line performance.”

 



 

In September 2003, the Company announced the completion of a $500,000 private placement of 625,000 of the Company’s common stock.

 

In closing, Kunik stated, “We are very pleased with the recent completion of the $500,000 common stock equity raise. These funds along with our current credit arrangement are expected to be utilized not only to fund working capital but also the planned growth of the business”.

 

Headquartered in Houston, Texas, Sharps is a leading developer of superior solutions for improving safety, efficiency and cost related to the proper disposal of medical waste by industry and consumers.  The Company’s products and services represent cutting edge solutions for a variety of industries dealing with the complexity of managing regulatory compliance, environmental sensitivity, employee and customer safety, corporate risk and operating costs related to medical waste disposal. Sharps is a leading proponent and participant in the development of public awareness and solutions for the safe disposal of needles, syringes and other sharps in the community setting.

 

Sharps Compliance Corp. is the exclusive supplier of Sharps Disposal by Mail systems to the Consumer Health Care division of Becton, Dickinson and Company. The Company also maintains an exclusive sales and marketing arrangement with Waste Management, Inc. whereby Sharps provides safe disposal systems and related services for Waste Management’s residential and commercial customers.

 

The Company also has a mutually exclusive joint marketing agreement with McKesson Health Solutions (“McKesson”), a subsidiary of McKesson Corporation, to co-market and sell the Sharps Disposal by Mail System™ products and services to pharmaceutical manufacturers and biotechnology companies. McKesson is a leader in the design, implementation and management of marketing programs, specialty pharmaceutical services and patient support centers that help pharmaceutical and biotechnology manufactures successfully commercialize their products.

 

Sharps Compliance Corp.’s common stock trades on the OTC Bulletin Board under the symbol SCOM.

 

Any forward-looking statements in this release are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Act of 1995.  Investors are cautioned that actual results may differ substantially from such forward-looking statements.  Forward-looking statements involve risks and uncertainties including, but not limited to, continued acceptance of the Company’s products and services in the marketplace, competitive factors, new products and technological changes, dependence upon third-party vendors, customer relations, government supervision and regulation, changes in industry practices, changes in third-party expense reimbursement procedures, and other risks detailed in the Company’s periodic filings with the Securities and Exchange Commission.

 

(Financial Highlights Follow)

 

2



 

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

 

 

Three Months Ended September 30,

 

 

 

 

 

 

 

 

 

2003

 

2002

 

 

 

(Unaudited)

 

(Unaudited)

 

 

 

 

 

 

 

REVENUES

 

$

1,997,212

 

$

2,048,868

 

 

 

 

 

 

 

COSTS AND EXPENSES:

 

 

 

 

 

Cost of revenues

 

1,217,710

 

1,381,390

 

Selling, general and administrative

 

836,386

 

841,811

 

Depreciation and amortization

 

38,658

 

21,151

 

 

 

 

 

 

 

Operating loss

 

(95,542

)

(195,484

)

 

 

 

 

 

 

INTEREST (EXPENSE) INCOME, net

 

(21,035

)

7,282

 

 

 

 

 

 

 

Net loss

 

$

(116,577

)

$

(188,202

)

 

 

 

 

 

 

BASIC AND DILUTED NET LOSS PER SHARE

 

$

(0.01

)

$

(0.02

)

 

 

 

 

 

 

SHARES USED IN COMPUTING BASIC AND DILUTED NET LOSS PER SHARE

 

9,960,811

 

9,822,023

 

 

 

 

 

 

 

 

3



 

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

 

September 30,
2003

 

June 30,
2003

 

 

 

(Unaudited)

 

 

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

281,507

 

$

135,884

 

Restricted cash

 

43,614

 

152,851

 

Accounts receivable, net

 

763,142

 

740,760

 

Inventory

 

403,786

 

299,136

 

Prepaid and other assets

 

100,253

 

125,808

 

Total current assets

 

1,592,302

 

1,454,439

 

Property and equipment, net

 

577,358

 

597,691

 

Intangible assets, net

 

1,950

 

 

Other assets

 

11,695

 

11,695

 

Total assets

 

$

2,183,305

 

$

2,063,825

 

 

 

 

 

 

 

Liabilities and stockholders’ (deficit) equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

462,575

 

$

567,918

 

Accrued liabilities

 

279,073

 

226,427

 

Deferred revenue — pump return

 

186,461

 

205,125

 

Current portion of deferred revenue — incineration

 

102,799

 

108,547

 

Current portion of deferred revenue — transportation

 

460,644

 

476,630

 

Notes payable and current portion of long-term debt

 

261,932

 

407,374

 

Current maturities of capital lease obligations

 

31,835

 

36,501

 

Total current liabilities

 

1,785,319

 

2,028,522

 

Long-term deferred revenue — incineration, net of current portion

 

33,977

 

35,794

 

Long-term deferred revenue — transportation, net of current portion

 

159,094

 

164,142

 

Long-term debt, net of current portion

 

16,096

 

45,563

 

Obligations under capital lease, net of current maturities

 

110,156

 

102,314

 

Other

 

34,750

 

27,000

 

Total liabilities

 

2,139,392

 

2,403,335

 

Stockholders’ (deficit) equity:

 

 

 

 

 

Total stockholders’ (deficit) equity

 

43,913

 

(339,510

)

Total liabilities and stockholders’ (deficit) equity

 

$

2,183,305

 

$

2,063,825

 

 

 

4